Litcius/Paper detail

Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial

Ze-Rui Zhao, Shiliang Liu, Ting Zhou, Gang Chen, Hao Long, Xiaodong Su, Xu Zhang, Jianhua Fu, Peng Lin, Lanjun Zhang, Tiehua Rong, Jiadi Wu, Zhichao Li, Huilin Su, Jiyang Chen, Yunpeng Yang, Yongbin Lin, Mian Xi, Hong Yang

2024The Lancet Respiratory Medicine28 citationsDOI

Topics & Concepts

MedicineRadiation therapyLung cancerChemotherapyNeoadjuvant therapyOncologyCancerRadiologySurgeryInternal medicineBreast cancerCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical Imaging
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial | Litcius